Search Results - "Teras, Juri"

ASO Author Reflection: Isolated Limb Infusion for Locally Advanced Melanoma in the Extremely Old Patient is Safe and Effective by Teras, Jüri, Kroon, Hidde M., Zager, Jonathan S.

Get full text

2-cm versus 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm: long-term follow-up of a multicentre, randomised trial by Utjés, Deborah, Malmstedt, Jonas, Teras, Jüri, Drzewiecki, Krzysztof, Gullestad, Hans Petter, Ingvar, Christian, Eriksson, Hanna, Gillgren, Peter

“…The optimal surgical excision margins are uncertain for patients with thick (>2 mm) localised cutaneous melanomas. In our previous report of this multicentre,…”
Get full text

New Baltic chapter of the E-AHPBA: uniting towards surgical quality, research and innovations by Gulla, Aiste, Ignatavicius, Povilas, Kvietkauskas, Mindaugas, Atstupens, Kristaps, Plaudis, Haralds, Kutner, Sander, Adamson, Martin, Barauskas, Giedrius, Ozolins, Arturs, Teras, Jüri, Strupas, Kestutis

Get full text

Safety and Efficacy of Tigecycline in Treatment of Skin and Skin Structure Infections: Results of a Double-Blind Phase 3 Comparison Study with Vancomycin-Aztreonam by BREEDT, Johannes, TERAS, Jüri, GARDOVSKIS, Janis, MARITZ, Frans Jacobus, VAASNA, Tiit, ROSS, Douglas Patrick, GIOUD-PAQUET, Martine, DARTOIS, Nathalie, ELLIS-GROSSE, Evelyn J, LOH, Evan

“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

First Eastern European experience of isolated limb infusion for in-transit metastatic melanoma confined to the limb: Is it still an effective treatment option in the modern era? by Teras, Jüri, Kroon, Hidde M., Thompson, John F., Teras, Marina, Pata, Pille, Mägi, Andrus, Teras, Roland M., Boudinot, Sirje Rüütel

“…Isolated limb infusion (ILI) with cytotoxic agents is a simple and effective treatment option for patients with melanoma in-transit metastases (ITMs) confined…”
Get full text

Molecular Aspects of the Isolated Limb Infusion Procedure by Teras, Jüri, Carr, Michael J, Zager, Jonathan S, Kroon, Hidde M

“…For decades, isolated limb infusion (ILI) and hyperthermic isolated limb perfusion (HILP) have been used to treat melanoma in-transit metastases and…”
Get full text

International Multicenter Experience of Isolated Limb Infusion for In-Transit Melanoma Metastases in Octogenarian and Nonagenarian Patients by Teras, Jüri, Kroon, Hidde M., Miura, John T., Kenyon-Smith, Tim, Beasley, Georgia M., Mullen, Dean, Farrow, Norma E., Mosca, Paul J., Lowe, Michael C., Farley, Clara R., Potdar, Aishwarya, Daou, Hala, Sun, James, Carr, Michael, Farma, Jeffrey M., Henderson, Michael A., Speakman, David, Serpell, Jonathan, Delman, Keith A., Smithers, B. Mark, Barbour, Andrew, Tyler, Douglas S., Coventry, Brendon J., Zager, Jonathan S., Thompson, John F.

“…Background Isolated limb infusion (ILI) is used to treat in-transit melanoma metastases confined to an extremity. However, little is known about its safety and…”
Get full text

Factors predicting toxicity and response following isolated limb infusion for melanoma: An international multi-centre study by Kenyon-Smith, Timothy J., Kroon, Hidde M., Miura, John T., Teras, Jüri, Beasley, Georgia M., Mullen, Dean, Farrow, Norma E., Mosca, Paul J., Lowe, Michael C., Farley, Clara R., Potdar, Aishwarya, Daou, Hala, Sun, James, Farma, Jeffrey M., Henderson, Michael A., Speakman, David, Serpell, Jonathan, Delman, Keith A., Smithers, B. Mark, Barbour, Andrew, Coventry, Brendon J., Tyler, Douglas S., Zager, Jonathan S., Thompson, John F.

“…Isolated limb infusion (ILI) is a minimally-invasive procedure for delivering high-dose regional chemotherapy to treat melanoma in-transit metastases confined…”
Get full text

Human Peripheral Blood Eosinophils Express High Levels of the Purinergic Receptor P2X4 by Paalme, Viiu, Rump, Airi, Mädo, Kati, Teras, Marina, Truumees, Birgit, Aitai, Helen, Ratas, Kristel, Bourge, Mickael, Chiang, Chi-Shiun, Ghalali, Aram, Tordjmann, Thierry, Teras, Jüri, Boudinot, Pierre, Kanellopoulos, Jean M, Rüütel Boudinot, Sirje

“…Extracellular nucleotides are important mediators of cell activation and trigger multiple responses via membrane receptors known as purinergic receptors (P2)…”
Get full text

A Comparison of the Efficacy and Safety of Intravenous Followed by Oral Delafloxacin With Vancomycin Plus Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections: A Phase 3, Multinational, Double-Blind, Randomized Study by O'Riordan, William, McManus, Alison, Teras, Juri, Poromanski, Ivan, Cruz-Saldariagga, Maria, Quintas, Megan, Lawrence, Laura, Liang, ShuJui, Cammarata, Sue

“…This phase 3 trial in acute bacterial skin and skin structure infections showed IV followed by oral delafloxacin to be noninferior to IV vancomycin/aztreonam…”
Get full text

Active surveillance of patients who have sentinel node positive melanoma: An international, multi‐institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT‐2) by Broman, Kristy Kummerow, Hughes, Tasha, Dossett, Lesly, Sun, James, Kirichenko, Dennis, Carr, Michael J., Sharma, Avinash, Bartlett, Edmund K., Nijhuis, Amanda A. G., Thompson, John F., Hieken, Tina J., Kottschade, Lisa, Downs, Jennifer, Gyorki, David E., Stahlie, Emma, Akkooi, Alexander, Ollila, David W., Frank, Jill, Song, Yun, Karakousis, Giorgos, Moncrieff, Marc, Nobes, Jenny, Vetto, John, Han, Dale, Farma, Jeffrey M., Deneve, Jeremiah L., Fleming, Martin D., Perez, Matthew C., Lowe, Michael C., Olofsson Bagge, Roger, Mattsson, Jan, Lee, Ann Y., Berman, Russell S., Chai, Harvey, Kroon, Hidde M., Teras, Juri, Teras, Roland M., Farrow, Norma E., Beasley, Georgia, Hui, Jane Yuet Ching, Been, Lukas, Kruijff, Schelto, Kim, Youngchul, Naqvi, Syeda Mahrukh Hussnain, Sarnaik, Amod A., Sondak, Vernon K., Zager, Jonathan S.

“…Background For patients with sentinel lymph node (SLN)‐positive cutaneous melanoma, the Second Multicenter Selective Lymphadenectomy trial demonstrated…”
Get full text

The efficacy of immune checkpoint blockade for melanoma in-transit with or without nodal metastases – A multicenter cohort study by Holmberg, Carl-Jacob, Ny, Lars, Hieken, Tina J., Block, Matthew S., Carr, Michael J., Sondak, Vernon K., Örtenwall, Christoffer, Katsarelias, Dimitrios, Dimitriou, Florentia, Menzies, Alexander M., Saw, Robyn PM, Rogiers, Aljosja, Straker, Richard J., Karakousis, Giorgos, Applewaite, Rona, Pallan, Lalit, Han, Dale, Vetto, John T., Gyorki, David E., Tie, Emilia Nan, Vitale, Maria Grazia, Ascierto, Paulo A., Dummer, Reinhard, Cohen, Jade, Hui, Jane YC, Schachter, Jacob, Asher, Nethanel, Helgadottir, H., Chai, Harvey, Kroon, Hidde, Coventry, Brendon, Rothermel, Luke D., Sun, James, Carlino, Matteo S., Duncan, Zoey, Broman, Kristy, Weber, Jeffrey, Lee, Ann Y., Berman, Russell S., Teras, Jüri, Ollila, David W., Long, Georgina V., Zager, Jonathan S., van Akkooi, Alexander, Olofsson Bagge, Roger

“…Guidelines addressing melanoma in-transit metastasis (ITM) recommend immune checkpoint inhibitors (ICI) as a first-line treatment option, despite the fact that…”
Get full text

International Center-Level Variation in Utilization of Completion Lymph Node Dissection and Adjuvant Systemic Therapy for Sentinel Lymph Node Positive Melanoma at Major Referral Centers by Broman, Kristy K., Hughes, Tasha M., Bredbeck, Brooke C., Sun, James, Kirichenko, Dennis, Carr, Michael J., Sharma, Avinash, Bartlett, Edmund K., Nijhuis, Amanda A. G., Thompson, John F., Hieken, Tina J., Kottschade, Lisa, Downs, Jennifer, Gyorki, David E., Stahlie, Emma, van Akkooi, Alexander, Ollila, David W., O'shea, Kristin, Song, Yun, Karakousis, Giorgos, Moncrieff, Marc, Nobes, Jenny, Vetto, John, Han, Dale, Hotz, Meghan, Farma, Jeffrey M., Deneve, Jeremiah L., Fleming, Martin D., Perez, Matthew, Baecher, Kirsten, Lowe, Michael, Bagge, Roger Olofsson, Mattsson, Jan, Lee, Ann Y., Berman, Russell S., Chai, Harvey, Kroon, Hidde M., Teras, Juri, Teras, Roland M., Farrow, Norma E., Beasley, Georgia M., Hui, Jane Yuet Ching, Been, Lukas, Kruijff, Schelto, Sinco, Brandy, Sarnaik, Amod A., Sondak, Vernon K., Zager, Jonathan S., Dossett, Lesly A.

“…The aim of this study was to determine overall trends and center-level variation in utilization of completion lymph node dissection (CLND) and adjuvant…”
Get full text

Surveillance of Sentinel Node-Positive Melanoma Patients with Reasons for Exclusion from MSLT-II: Multi-Institutional Propensity Score Matched Analysis by Broman, Kristy K., Hughes, Tasha M., Dossett, Lesly A., Sun, James, Carr, Michael J., Kirichenko, Dennis A., Sharma, Avinash, Bartlett, Edmund K., Nijhuis, Amanda AG, Thompson, John F., Hieken, Tina J., Kottschade, Lisa, Downs, Jennifer, Gyorki, David E., Stahlie, Emma, van Akkooi, Alexander, Ollila, David W., Frank, Jill, Song, Yun, Karakousis, Giorgos, Moncrieff, Marc, Nobes, Jenny, Vetto, John, Han, Dale, Farma, Jeffrey, Deneve, Jeremiah L., Fleming, Martin D., Perez, Matthew, Baecher, Kirsten, Lowe, Michael, Bagge, Roger Olofsson, Mattsson, Jan, Lee, Ann Y., Berman, Russell S., Chai, Harvey, Kroon, Hidde M., Teras, Roland M., Teras, Juri, Farrow, Norma E., Beasley, Georgia M., Hui, Jane YC, Been, Lukas, Kruijff, Schelto, Boulware, David, Sarnaik, Amod A., Sondak, Vernon K., Zager, Jonathan S.

“…In sentinel lymph node (SLN)-positive melanoma, two randomized trials demonstrated equivalent melanoma-specific survival with nodal surveillance vs completion…”
Get full text

International Center-Level Variation in Utilization of Completion Lymph Node Dissection and Adjuvant Systemic Therapy for Sentinel Lymph Node Positive Melanoma by Broman, Kristy K., Hughes, Tasha M., Bredbeck, Brooke C., Sun, James, Kirichenko, Dennis, Carr, Michael J., Sharma, Avinash, Bartlett, Edmund K., Nijhuis, Amanda A. G., Thompson, John F., Hieken, Tina J., Kottschade, Lisa, Downs, Jennifer, Gyorki, David E., Stahlie, Emma, van Akkooi, Alexander, Ollila, David W., O’shea, Kristin, Song, Yun, Karakousis, Giorgos, Moncrieff, Marc, Nobes, Jenny, Vetto, John, Han, Dale, Hotz, Meghan, Farma, Jeffrey M., Deneve, Jeremiah L., Fleming, Martin D., Perez, Matthew, Baecher, Kirsten, Lowe, Michael, Bagge, Roger Olofsson, Mattsson, Jan, Lee, Ann Y., Berman, Russell S., Chai, Harvey, Kroon, Hidde M., Teras, Juri, Teras, Roland M., Farrow, Norma E., Beasley, Georgia M., Hui, Jane Yuet Ching, Been, Lukas, Kruijff, Schelto, Sinco, Brandy, Sarnaik, Amod A., Sondak, Vernon K., Zager, Jonathan S., Dossett, Lesly A.

Get full text

A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae by Vasilev, Krasimir, Reshedko, Galina, Orasan, Remus, Sanchez, Miguel, Teras, Juri, Babinchak, Tim, Dukart, Gary, Cooper, Angel, Dartois, Nathalie, Gandjini, Hassan, Orrico, Russ, Ellis-Grosse, Evelyn

“…Objectives To evaluate the efficacy and safety of tigecycline in patients with selected serious infections caused by resistant Gram-negative bacteria, or…”
Get full text

A Global Phase 3 Study of Delafloxacin Compared to Vancomycin/Aztreonam in Patients with Acute Bacterial Skin and Skin Structure Infections by Riordan, W O', Manus, Alison Mc, Teras, Juri, Poromanski, Ivan, Saldariagga, Maria Cruz, Quintas, Megan, Lawrence, Laura, Cammarata, Sue

Get full text

First Eastern European Experience of Isolated Limb Infusion for In-Transit Metastatic Melanoma Confined to the Limb: Is it still an Effective Treatment Option in the Modern Era? by Teras, Jüri, Kroon, Hidde, Mägi, Andrus, Teras, Marina, Pata, Pille, Teras, Roland Martin, Boudinot, Sirje Rüütel

Get full text

A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae: Tigecycline, a therapeutic option from a new antimicrobial class (the glycylcyclines) in an era of increasing resistance by VASILEV, Krasimir, RESHEDKO, Galina, ORRICO, Russ, ELLIS-GROSSE, Evelyn, ORASAN, Remus, SANCHEZ, Miguel, TERAS, Juri, BABINCHAK, Tim, DUKART, Gary, COOPER, Angel, DARTOIS, Nathalie, GANDJINI, Hassan

Get full text

2-cm versus 4-cm surgical excision margin for thick (>2 mm) primary malignant melanoma: long-term follow-up of a multicenter randomized trial by Teras, Jüri, Utjés, Deborah, Malmstedt, Jonas, Drzewiecki, Krzysztof, Gullestad, Hans Petter, Ingvar, Christian, Eriksson, Hanna, Gillgren, Peter

Get full text